Healius (HLS.AX) Stock Price

Healius Price

ASX·CLOSED
0.38AUD+0.0100 (+2.63 %)
Market closed

Over the last 19 years Healius grew revenue by 9.4% annually, reaching 1.34 B AUD. Earnings per share have grown at 3.8% per year over the last 16 years. For Healius, the net margin of -11.2% is down versus 2.3% a few years ago. At today's price the dividend yield works out to roughly 153.25%. The consensus 12-month price target for Healius is 0.77 AUD, about 98.7% above where the stock trades today. Of 15 analysts, 1 rate the stock a buy — an overall Sell consensus. The stock trades about 22% above its 52-week low.

Healius stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Healius over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Healius stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Healius's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Healius Stock Price History
DateHealius Price
8/3/20260.38 AUD
7/31/20260.38 AUD
7/30/20260.37 AUD
7/29/20260.38 AUD
7/28/20260.35 AUD
7/27/20260.35 AUD
7/24/20260.35 AUD
7/23/20260.35 AUD
7/22/20260.35 AUD
7/21/20260.36 AUD
7/20/20260.37 AUD
7/17/20260.38 AUD
7/16/20260.40 AUD
7/15/20260.39 AUD
7/14/20260.39 AUD
7/13/20260.38 AUD
7/10/20260.39 AUD
7/9/20260.39 AUD
7/8/20260.38 AUD
7/7/20260.38 AUD
7/6/20260.38 AUD
7/3/20260.38 AUD
7/2/20260.38 AUD
7/1/20260.36 AUD
6/30/20260.40 AUD
6/29/20260.40 AUD
6/26/20260.37 AUD
6/25/20260.35 AUD
6/24/20260.36 AUD
6/23/20260.35 AUD
6/22/20260.38 AUD
6/19/20260.41 AUD
6/18/20260.39 AUD
6/17/20260.40 AUD
6/16/20260.39 AUD
6/15/20260.40 AUD
6/12/20260.36 AUD
6/11/20260.34 AUD
6/10/20260.31 AUD
6/9/20260.31 AUD
6/5/20260.32 AUD
6/4/20260.32 AUD
6/3/20260.32 AUD
6/2/20260.32 AUD
6/1/20260.34 AUD
5/29/20260.34 AUD
5/28/20260.35 AUD
5/27/20260.35 AUD
5/26/20260.35 AUD
5/25/20260.35 AUD
5/22/20260.36 AUD
5/21/20260.35 AUD
5/20/20260.34 AUD
5/19/20260.37 AUD
5/18/20260.35 AUD
5/15/20260.34 AUD
5/14/20260.37 AUD
5/13/20260.38 AUD
5/12/20260.49 AUD
5/11/20260.50 AUD
5/8/20260.50 AUD
5/7/20260.53 AUD
5/6/20260.50 AUD
5/5/20260.48 AUD
5/4/20260.50 AUD
5/1/20260.50 AUD
4/30/20260.50 AUD
4/29/20260.51 AUD
4/28/20260.51 AUD
4/27/20260.54 AUD
4/24/20260.53 AUD
4/23/20260.54 AUD
4/22/20260.54 AUD
4/21/20260.56 AUD
4/20/20260.54 AUD
4/17/20260.54 AUD
4/16/20260.55 AUD
4/15/20260.51 AUD
4/14/20260.51 AUD
4/13/20260.51 AUD
4/10/20260.50 AUD
4/9/20260.51 AUD
4/8/20260.52 AUD
4/7/20260.51 AUD
4/2/20260.52 AUD
4/1/20260.55 AUD
3/31/20260.56 AUD
3/30/20260.54 AUD
3/27/20260.56 AUD
3/26/20260.58 AUD
3/25/20260.57 AUD
3/24/20260.54 AUD
3/23/20260.56 AUD
3/20/20260.57 AUD
3/19/20260.57 AUD
3/18/20260.59 AUD
3/17/20260.59 AUD
3/16/20260.57 AUD
3/13/20260.60 AUD
3/12/20260.60 AUD
3/11/20260.62 AUD
3/10/20260.63 AUD
3/9/20260.61 AUD
3/6/20260.63 AUD
3/5/20260.63 AUD
3/4/20260.63 AUD
3/3/20260.66 AUD
3/2/20260.67 AUD
2/27/20260.69 AUD
2/26/20260.69 AUD
2/25/20260.68 AUD
2/24/20260.67 AUD
2/23/20260.69 AUD
2/20/20260.69 AUD
2/19/20260.74 AUD
2/18/20260.76 AUD
2/17/20260.81 AUD
2/16/20260.80 AUD
2/13/20260.77 AUD
2/12/20260.80 AUD
2/11/20260.86 AUD
2/10/20260.87 AUD
2/9/20260.88 AUD
2/6/20260.90 AUD
2/5/20260.92 AUD
2/4/20260.94 AUD
2/3/20260.94 AUD
2/2/20260.93 AUD
1/30/20260.90 AUD
1/29/20260.90 AUD
1/28/20260.92 AUD
1/27/20260.94 AUD
1/23/20260.95 AUD
1/22/20260.94 AUD
1/21/20260.94 AUD
1/20/20260.94 AUD
1/19/20260.93 AUD
1/16/20260.94 AUD
1/15/20260.96 AUD
1/14/20261.02 AUD
1/13/20261.04 AUD
1/12/20261.00 AUD
1/9/20260.98 AUD
1/8/20260.95 AUD
1/7/20260.95 AUD
1/6/20260.89 AUD
1/5/20260.89 AUD
1/2/20260.91 AUD
12/31/20250.90 AUD
12/30/20250.92 AUD
12/29/20250.92 AUD
12/24/20250.94 AUD
12/23/20250.95 AUD
12/22/20250.94 AUD
12/19/20250.95 AUD
12/18/20250.95 AUD
12/17/20250.96 AUD
12/16/20250.98 AUD
12/15/20250.98 AUD
12/12/20250.98 AUD
12/11/20250.98 AUD
12/10/20250.96 AUD
12/9/20250.99 AUD
12/8/20251.00 AUD
12/5/20250.98 AUD
12/4/20250.99 AUD
12/3/20251.00 AUD
12/2/20251.04 AUD
12/1/20251.00 AUD
11/28/20250.98 AUD
11/27/20251.00 AUD
11/26/20251.00 AUD
11/25/20250.96 AUD
11/24/20250.93 AUD
11/21/20250.89 AUD
11/20/20250.94 AUD
11/19/20250.88 AUD
11/18/20250.88 AUD
11/17/20250.90 AUD
11/14/20250.89 AUD
11/13/20250.89 AUD
11/12/20250.91 AUD
11/11/20250.88 AUD
11/10/20250.88 AUD
11/7/20250.87 AUD
11/6/20250.87 AUD
11/5/20250.86 AUD
11/4/20250.88 AUD
11/3/20250.88 AUD
10/31/20250.89 AUD
10/30/20250.84 AUD
10/29/20250.80 AUD
10/28/20250.80 AUD
10/27/20250.81 AUD
10/24/20250.82 AUD
10/23/20250.81 AUD
10/22/20250.79 AUD
10/21/20250.79 AUD
10/20/20250.77 AUD
10/17/20250.80 AUD
10/16/20250.81 AUD
10/15/20250.79 AUD
10/14/20250.74 AUD
10/13/20250.77 AUD
10/10/20250.81 AUD
10/9/20250.81 AUD
10/8/20250.80 AUD
10/7/20250.81 AUD
10/6/20250.81 AUD
10/3/20250.81 AUD
10/2/20250.77 AUD
10/1/20250.75 AUD
9/30/20250.75 AUD
9/29/20250.75 AUD
9/26/20250.75 AUD
9/25/20250.77 AUD
9/24/20250.75 AUD
9/23/20250.77 AUD
9/22/20250.80 AUD
9/19/20250.78 AUD
9/18/20250.78 AUD
9/17/20250.77 AUD
9/16/20250.77 AUD
9/15/20250.80 AUD
9/12/20250.79 AUD
9/11/20250.79 AUD
9/10/20250.80 AUD
9/9/20250.81 AUD
9/8/20250.82 AUD
9/5/20250.82 AUD
9/4/20250.85 AUD
9/3/20250.85 AUD
9/2/20250.84 AUD
9/1/20250.86 AUD
8/29/20250.86 AUD
8/28/20250.91 AUD
8/27/20250.96 AUD
8/26/20250.94 AUD
8/25/20250.83 AUD
8/22/20250.83 AUD
8/21/20250.70 AUD
8/20/20250.81 AUD
8/19/20250.81 AUD
8/18/20250.81 AUD
8/15/20250.80 AUD
8/14/20250.80 AUD
8/13/20250.79 AUD
8/12/20250.81 AUD
8/11/20250.83 AUD
8/8/20250.85 AUD
8/7/20250.84 AUD
8/6/20250.80 AUD
8/5/20250.75 AUD
Access this data via the Eulerpool API
Get Free API Key

Healius Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.71 B AUD
98.10 M AUD
-367.80 M AUD
Jan 1, 2024
1.27 B AUD
7.30 M AUD
-645.80 M AUD
Jan 1, 2025
1.34 B AUD
200,000.00 AUD
-151.20 M AUD
Jan 1, 2026 (e)
1.38 B AUD
-57.31 M AUD
-11.54 M AUD
Jan 1, 2027 (e)
1.42 B AUD
-59.10 M AUD
-2.05 M AUD
Jan 1, 2028 (e)
1.48 B AUD
-61.37 M AUD
5.98 M AUD
Jan 1, 2029 (e)
1.50 B AUD
-62.51 M AUD
11.62 M AUD
Jan 1, 2030 (e)
1.67 B AUD
138.27 M AUD
62.26 M AUD

Healius Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 11:41 AM
 
REVENUEB AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
DIV.AUD
DIV. GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
1.641.661.701.561.561.902.291.711.271.341.381.421.481.501.671.78
3.931.042.77-8.33-0.3222.0320.42-25.44-25.505.742.533.123.801.9011.246.40
89.8289.3888.2687.4587.2285.7986.6386.9384.0384.0884.0884.0884.0884.0884.0884.08
1.471.481.501.371.361.631.981.481.071.131.161.191.241.261.411.50
166.00117.00114.00107.0086.00255.00484.0098.007.00–-57.00-59.00-61.00-62.00138.00–
10.127.066.696.855.5213.4221.155.740.55–-4.14-4.15-4.14-4.138.25–
74.00-516.004.0055.00-70.0043.00307.00-367.00-645.00-151.00-11.00-2.005.0011.0062.0080.00
-41.73-797.30-100.781,275.00-227.27-161.43613.95-219.5475.75-76.59-92.72-81.82-350.00120.00463.6429.03
0.160.150.150.100.040.190.230.16––0.160.170.17–––
-38.46-6.25–-33.33-60.00375.0021.05-30.43–––6.25––––
539.19540.46521.97607.40622.74676.90639.48615.55659.76726.13726.13726.13726.13726.13726.13726.13
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Healius generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Healius retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Healius's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Healius has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Healius's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Healius stock margins

The Healius margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Healius. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Healius.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
85.76 %
13.44 %
2.30 %
Jan 1, 2022
86.61 %
21.16 %
13.45 %
Jan 1, 2023
86.89 %
5.75 %
-21.55 %
Jan 1, 2024
84.04 %
0.57 %
-50.78 %
Jan 1, 2025
84.08 %
0.01 %
-11.25 %
Jan 1, 2026 (e)
84.08 %
-4.16 %
-0.84 %
Jan 1, 2027 (e)
84.08 %
-4.16 %
-0.14 %
Jan 1, 2028 (e)
84.08 %
-4.16 %
0.41 %

Healius Stock Revenue, EBIT, Earnings per Share

The Healius earnings per share therefore indicates how much revenue Healius has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
2.81 AUD
0.38 AUD
0.06 AUD
Jan 1, 2022
3.58 AUD
0.76 AUD
0.48 AUD
Jan 1, 2023
2.77 AUD
0.16 AUD
-0.60 AUD
Jan 1, 2024
1.93 AUD
0.01 AUD
-0.98 AUD
Jan 1, 2025
1.85 AUD
0.00 AUD
-0.21 AUD
Jan 1, 2026 (e)
1.90 AUD
-0.08 AUD
-0.02 AUD
Jan 1, 2027 (e)
1.96 AUD
-0.08 AUD
-0.00 AUD
Jan 1, 2028 (e)
2.03 AUD
-0.08 AUD
0.01 AUD

Healius business model & stock analysis

Healius Ltd is an Australian company operating in the healthcare sector with its headquarters in Sydney. The company's history dates back to 2002 when Primary Health Care Limited was established, which was eventually renamed Healius Ltd in 2018. Healius operates in various business areas, all revolving around the goal of providing comprehensive healthcare. The company operates a wide network of medical services and facilities throughout Australia. Some of Healius' divisions include medical centers, radiology practices, pathology laboratories, and hospitals. In total, the company operates over 70 medical centers across Australia. These facilities offer a wide range of medical services, including general practitioners, dentistry, physiotherapy, and nutritional counseling. Additionally, Healius operates a number of radiology practices specializing in imaging of the human body. These services are used for disease diagnosis and surgical planning. Various imaging techniques such as X-ray, CT, and MRI are offered in Healius' radiology practices. Pathology laboratories are another important division of Healius. Here, blood and tissue cells are examined for their health and functionality. These diagnostic procedures are used to detect and treat diseases. Another important aspect of Healius is the operation of hospitals. The company owns Gosford Private Hospital on the central coast of New South Wales. The hospital offers a wide range of surgeries and other medical procedures, specializing in the care of cancer patients. Healius also focuses on utilizing modern technology to enhance its medical services. The company utilizes advanced data analytics tools to identify trends in patient care, enabling improvements and more effective treatments and therapies. In particular, Healius has been at the forefront of telemedicine. The company operates the "feeling.net" app, utilized by patients for self-monitoring their mood to ensure the best possible care. Overall, Healius offers a wide spectrum of services ranging from general healthcare to specialized surgeries. The company values providing comprehensive and professional care to its patients, utilizing state-of-the-art technologies. By combining top-notch medical facilities and innovative technology, Healius has become a significant player in Australia's healthcare sector.

Healius SWOT Analysis

Strengths

  • Strong market presence: Healius Ltd is a renowned healthcare company with a significant market share in Australia.
  • Diversified service portfolio: The company offers a wide range of healthcare services including pathology, medical centers, and imaging services, providing multiple revenue streams.
  • Established brand: Healius has built a strong brand reputation over the years, known for its quality healthcare services and commitment to patient care.
  • Extensive network: The company has a large network of medical centers and pathology labs across the country, allowing easy access to healthcare services for patients.
  • Technological advancements: Healius has embraced technology and implemented innovative solutions to enhance healthcare delivery, such as telehealth services and digital platforms.

Weaknesses

  • Dependency on government funding: Healius receives a significant portion of its revenue from government contracts, which exposes it to potential changes in healthcare policies and funding.
  • Rising competition: The healthcare industry in Australia is highly competitive, with numerous private healthcare providers and medical practitioners vying for market share.
  • Reliance on key personnel: The success of Healius heavily relies on the expertise and skills of its healthcare professionals, and the loss of key personnel could disrupt operations.

Opportunities

  • Growing healthcare market: The demand for healthcare services is expected to increase due to an aging population and a greater focus on health and well-being.
  • Expansion into new regions: Healius can explore opportunities to expand its operations into underserved regions or target international markets for business growth.
  • Digital health advancements: The rapid development of digital health technologies presents opportunities for Healius to further enhance its healthcare services and improve patient experience.

Threats

  • Regulatory changes: Changes in healthcare regulations and government policies can impact the operations and profitability of Healius.
  • Economic uncertainties: Economic downturns or financial crises can lead to reduced healthcare spending and affect the demand for Healius' services.
  • Public perception and trust: Negative publicity or patient dissatisfaction can damage the reputation of Healius and hinder patient acquisition and retention.

Healius Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Healius historical P/E ratio, EBIT multiple, and P/S ratio

Healius annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Healius shares outstanding

The number of shares of Healius was 726.13 M in 2025. This indicates how many shares Healius is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
676.90 M Stocks
Jan 1, 2022
639.48 M Stocks
Jan 1, 2023
615.55 M Stocks
Jan 1, 2024
659.76 M Stocks
Jan 1, 2025
726.13 M Stocks
Jan 1, 2026 (e)
726.13 M Stocks
Jan 1, 2027 (e)
726.13 M Stocks
Jan 1, 2028 (e)
726.13 M Stocks

Healius Dividend History

26 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.59AUD↑ 643.7%1×
May 9, 20250.59AUD↑ 588.3%1/1
20230.08AUD↓ 65.3%—
20220.23AUD↑ 20.8%2×
20210.19AUD↑ 409.6%2×
20200.04AUD↓ 63.9%1×
20190.10AUD↓ 32.1%2×
20180.15AUD↑ 0.0%2×
20170.15AUD↓ 5.0%2×
20160.16AUD↓ 39.2%2×
20150.26AUD↓ 8.3%2×

Healius dividend history and estimates

In 2025, Healius paid a dividend amounting to 0.59 AUD. Dividend means that Healius distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2020
0.04 AUD
0.00 AUD
0.00 AUD
Jan 1, 2021 (e)
0.19 AUD
-0.00 AUD
0.00 AUD
Jan 1, 2022
0.23 AUD
0.00 AUD
0.00 AUD
Jan 1, 2023 (e)
0.08 AUD
0.08 AUD
0.00 AUD
Jan 1, 2025 (e)
0.59 AUD
0.00 AUD
0.00 AUD
Jan 1, 2026 (e)
0.00 AUD
0.16 AUD
0.59 AUD
Jan 1, 2027 (e)
0.00 AUD
0.17 AUD
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
0.17 AUD
0.00 AUD

Healius dividend payout ratio

In 2025, Healius had a payout ratio of -295.00%. The payout ratio indicates the percentage of the company's profits that Healius distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
315.48 %
Jan 1, 2022
44.08 %
Jan 1, 2023
156.25 %
Jan 1, 2024
171.93 %
Jan 1, 2025
-295.00 %
Jan 1, 2026 (e)
124.09 %
Jan 1, 2027 (e)
150.76 %
Jan 1, 2028 (e)
2,122.12 %

Current Healius forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
7.41 %
Buy
6.67 % (1)
Hold
33.33 % (5)
Sell
60.00 % (9)
12M Price Target
0.77
Last Price
0.38
Currency
AUD
12M Return Potential
98.70 %
LTM Return
0 %

Healius Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
2/26/20240.02AUD-846.56 MAUD-2024 Q2
8/30/20230.09AUD-995.59 MAUD-2023 Q4
2/21/20230.09AUD-999.81 MAUD-2023 Q2
8/30/20220.12AUD-1.04 BAUD-2022 Q4
2/23/20220.42AUD-1.30 BAUD-2022 Q2
8/30/20210.13AUD-1.03 BAUD-2021 Q4
2/24/20210.11AUD-952.14 MAUD-2021 Q2
8/21/20200.02AUD-723.08 MAUD-2020 Q4
2/26/20200.08AUD-944.11 MAUD-2020 Q2
8/16/20190.09AUD-980.68 MAUD-2019 Q4

EESG©

Eulerpool ESG Scorecard© for the Healius stock

64/100
99
Environment
53
Social
39
Governance
E

Environment

20
Scope 1 - Direct Emissions5,878
Scope 2 - Indirect emissions from purchased energy24,402
Scope 3 - Indirect emissions within the value chain6,529.2
Total CO₂ emissions30,280
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees73.8
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Healius shareholder structure

% Name
6.60836%
Pinnacle Investment Management Group Ltd
Pinnacle Investment Management Group Ltd
6.11708%
Colonial First State Investments Limited
Colonial First State Investments Limited
5.38242%
RQI Investors
RQI Investors
4.92955%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.85709%
State Street Investment Management Australia Ltd.
State Street Investment Management Australia Ltd.
2.67753%
First Sentier Investors
First Sentier Investors

Healius Beneficial Ownership Filings (SEC 13D/G)

Free Float
78.0%
Float Shares
-
Shares Outstanding
-

Healius Executives and Management Board

12 members · avg. age 64 · 33 % women

PA

Mr. Paul Anderson

Chief Executive Officer, Managing Director, Director · since 2023

944,623.00 AUD

Management

SH

Mr. Stephen Humphries

Chief Financial Officer, Company Secretary

262,964.00 AUD
PA

Mr. Prasad Arav

Group Executive - Digital and Technology and Strategy

–
PB

Ms. Paula Bayliss

Group Executive - People & Culture

–
PL

Dr. Phil Lucas

Group Executive - Lumus Imaging

–

Board of Directors

KM

Ms. Kathryn Mckenzie (63)

Interim Non-Executive Independent Chairman of the Board

269,984.00 AUD
SE

Ms. Sally Evans

Non-Executive Independent Director

185,000.00 AUD
CT

Mr. Charles Taylor

Non-Executive Independent Director

174,821.00 AUD
PM

Prof. John Mattick

Non-Executive Independent Director

170,000.00 AUD
MS

Dr. Michael Stanford (65)

Non-Executive Director

138,743.00 AUD
NV

Mr. Neil Vinson

Non-Executive Director

–

Healius Supply Chain

Healius Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
8 companies
#NameTrend
1
Pro Medicus
Supplier·Health Care Technology·AU
0.95
0.75
0.61
0.83
0.80
0.95
2
JPMorgan Chase
Supplier·Customer·Banks·US
0.17
-0.25
0.10
0.70
0.52
0.86
3
Arena
Supplier·Equity Real Estate Investment Trusts (REITs)·AU
0.91
0.31
0.08
-0.45
-0.07
0.83
4
A2B Australia
Supplier·Road & Rail·AU
0.66
0.04
0.02
0.07
0.16
0.83
5
Dexus
Supplier·Equity Real Estate Investment Trusts (REITs)·AU
-0.35
0.01
0.02
0.61
0.32
0.82
#NameTrend
1
Bill Identity
Supplier·Software·AU
0.41
-0.23
0.15
0.69
0.26
-0.63

Frequently asked questions about Healius

Healius Ltd is a leading healthcare company based in Australia. The company's business model revolves around delivering exceptional healthcare services and solutions. Healius operates a diverse range of medical centers, pathology laboratories, and imaging clinics throughout the country. With a focus on patient care and innovation, Healius aims to provide accessible and high-quality healthcare to individuals and communities. The company's comprehensive range of services includes general practitioner consultations, pathology testing, radiology imaging, and specialty healthcare options. Healius' business model centers on delivering efficient, integrated, and patient-centric healthcare solutions, making it a prominent player in the Australian healthcare industry.

Healius Ltd is primarily active in the healthcare industry.

The main competitors of Healius Ltd in the market include companies such as Sonic Healthcare, Primary Health Care, and Ramsay Health Care.

Healius Ltd, formerly known as Primary Health Care Ltd, is a leading Australian healthcare company. Established in 1985, Healius has a rich history of providing quality healthcare services to patients nationwide. Over the years, the company has evolved and expanded its offerings, including medical centers, pathology services, and diagnostic imaging. With a network of over 2,000 doctors and healthcare professionals, Healius focuses on delivering patient-centric care and innovative solutions. The company's commitment to excellence has made it a trusted name in the healthcare industry, providing comprehensive and accessible medical services to individuals and communities across Australia.

Healius Ltd has achieved significant milestones over the years. Some notable achievements include expanding its network of medical centers, introducing innovative healthcare services, and forging strategic partnerships. The company has also demonstrated consistent financial growth, delivering strong revenue and earnings results. Furthermore, Healius Ltd has focused on enhancing patient experiences and improving healthcare outcomes through technological advancements and process improvements. With its commitment to excellence, Healius Ltd continues to make strides in the healthcare industry, solidifying its position as a leading provider of integrated healthcare services.

Healius Ltd is primarily present in Australia.

Healius Ltd represents values of integrity, excellence, collaboration, and compassion. The company is committed to delivering high-quality healthcare services to its patients, fostering a culture of trust and accountability. With a focus on innovation and patient-centered care, Healius aims to provide accessible and efficient healthcare solutions. As a leading healthcare company in Australia, Healius embraces a corporate philosophy centered around continuously improving patient outcomes, investing in advanced technologies, and maintaining strong ethical standards. With its dedicated and skilled team, Healius is devoted to making a positive difference in people's lives through its diversified range of services and commitment to quality healthcare delivery.

Analysts currently set an average price target of 0.75 AUD for the Healius stock (median: 0.77 AUD), implying +95.2 % versus the latest price. The consensus is based on 15 analyst ratings.

Healius Analyst Price Targets 2026

15 analysts currently rate the Healius stock: 0 recommend buying, 7 holding and 8 selling. For 2026, analysts expect Healius to generate revenue of 1.38 B AUD and earnings per share of -0.02 AUD.

Healius Analyst Price Targets 2026

Converted at the current exchange rate, the Healius share trades at 0.23 EUR (0.38 AUD).

The Healius share (HLS.AX) is listed on 4 stock exchanges, including: Frankfurt (PGZ.F), Düsseldorf (PGZ.DU), SIX (Zürich) (PGZ.SW), ASX (HLS.AX).

Healius Ltd is an Australian company that offers a comprehensive portfolio of healthcare services. It is a leading provider of integrated medical services, focusing on medical imaging, pathology, radiology, telemedicine, and general medicine. The company was founded in 2018 and is headquartered in Sydney, Australia. The following describes Healius Ltd's business model in more detail, as well as the various divisions and products the company offers. Business model: Healius Ltd specializes in integrated medical services. The company offers a wide range of products and services at medical locations in Australia to ensure optimal customer satisfaction. The advantage of this business model is that it provides a broad customer base and the opportunity to offer various services to generate revenue. Divisions: Healius Ltd offers a range of specialties including medical imaging, pathology, radiology, telemedicine, and general medicine. It is a leading provider of integrated medical services in Australia. The company performs medical diagnostic tests and provides consulting services to ensure quick diagnosis and proper treatment for its customers. Products: Medical imaging and radiology are the core competencies of Healius Ltd. The company has state-of-the-art technology for performing X-rays, CT scans, MRIs, ultrasound examinations, etc. Moreover, the company offers pathology services for disease diagnosis and medical tests to enable accurate medical diagnoses. Telemedicine is another important service provided by Healius Ltd. The company offers virtual doctor consultations, allowing customers to address their health issues from the comfort of their homes. The company also provides an online service for patients to access their medical history. In summary, Healius Ltd is a leading provider of medical services in Australia, offering a wide range of products and services to ensure optimal customer satisfaction. The company has a strong presence in various specialties such as medical imaging, pathology, radiology, telemedicine, and general medicine. The company has strong growth potential as it has a broad customer base and offers a comprehensive portfolio of services and products to generate revenue.

The expected revenue of Healius is 1.38 B AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Healius is -11.54 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Healius is currently -24.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Healius stock.

The price-to-sales ratio (P/S) of Healius is currently 0.20. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Healius stock.

The Eulerpool Quality Score for Healius is 0/10.

The ISIN of Healius is AU0000033359. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Healius is A2PAL9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Healius is HLS.AX. The ticker symbol is used to trade Healius shares on the stock exchange.

Over the past 12 months, Healius paid a dividend of 0.59 AUD . This corresponds to a dividend yield of about 153.25 %. For the coming 12 months, Healius is expected to pay a dividend of 0.17 AUD.

The current dividend yield of Healius is 153.25 %.

Healius pays a dividend, distributed in the months of , , , .

Healius paid dividends every year for the past 1 years.

For the upcoming 12 months, dividends amounting to 0.17 AUD are expected. This corresponds to a dividend yield of 43.97 %.

Healius is assigned to the 'Health' sector.

To receive the latest dividend of Healius from amounting to 0.59 AUD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Healius are distributed in AUD.

All fundamentals and in-depth analysis of Healius

Our stock analysis for Healius stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healius. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Healius Stock
Healius Revenue→
Healius Stock
Healius Net Income→
Healius Stock
Healius P/E→
Healius Stock
Healius P/S→
Healius Stock
Healius EBIT→
Healius Stock
Healius Dividend→
Healius Stock
Healius Directors Dealings→
Healius Stock
Healius Stocks→
Healius Stock
Healius Market capitalization→
Healius Stock
Healius Debt→
Healius Stock
Healius Liabilities→
Healius Stock
Healius Equity→
Healius Stock
Healius AAQS→
Healius Stock
Healius Employees→
Healius Stock
Healius ROE→
Healius Stock
Healius ROA→
Healius Stock
Healius ROCE→
Healius Stock
Healius News→
Healius Stock
Healius Analyst Price Targets→

Health Stocks

Health CatalystHealios KKHealth DiscoveryHCW BiologicsHealth&Life CoHcmed Innovations CoHealthcare Global EnterprisesHCA HealthcareHealthcare TriangleHC Surgical SpecialistsHealthconnHBL Hadasit Bio HoldingsAll Stocks A–Z →